Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1BWilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Klinik for Børn, Copenhagen, Denmark.
Department of Clinical Genetics, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
CHU Nantes, Service de Génétique Médicale, Nantes, France.
CHU Nantes, Service de Génétique Médicale, Nantes, France.
Department of Pediatrics, University of Siena, Siena, Italy.
Medical Genetics, Department of Biotechnology, University of Siena, Siena, Italy.
Medical Genetics, Department of Biotechnology, University of Siena, Siena, Italy.
Medical Genetics, Department of Biotechnology, University of Siena, Siena, Italy.
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Institut de Génétique Médicale, Hopital Jeanne de Flandre, CHRU de Lille, Lille, France.
Clinique de Génétique Médicale, CHRU de Lille, Lille, France.
Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Show others and affiliations
2012 (English)In: Clinical Genetics, ISSN 0009-9163, E-ISSN 1399-0004, Vol. 82, no 3, p. 248-255Article in journal (Other academic) Published
Abstract [en]
Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B. Corpus callosum abnormalities are common brain malformations with a wide clinical spectrum ranging from severe intellectual disability to normal cognitive function. The etiology is expected to be genetic in as much as 30-50% of the cases, but the underlying genetic cause remains unknown in the majority of cases. By next-generation mate-pair sequencing we mapped the chromosomal breakpoints of a patient with a de novo balanced translocation, t(1;6)(p31;q25), agenesis of corpus callosum (CC), intellectual disability, severe speech impairment, and autism. The chromosome 6 breakpoint truncated ARID1B which was also truncated in a recently published translocation patient with a similar phenotype. Quantitative polymerase chain reaction (Q-PCR) data showed that a primer set proximal to the translocation showed increased expression of ARID1B, whereas primer sets spanning or distal to the translocation showed decreased expression in the patient relative to a non-related control set. Phenotype-genotype comparison of the translocation patient to seven unpublished patients with various sized deletions encompassing ARID1B confirms that haploinsufficiency of ARID1B is associated with CC abnormalities, intellectual disability, severe speech impairment, and autism. Our findings emphasize that ARID1B is important in human brain development and function in general, and in the development of CC and in speech development in particular.
Place, publisher, year, edition, pages
John Wiley & Sons, 2012. Vol. 82, no 3, p. 248-255
Keywords [en]
ARID1B, autism spectrum disorder, chromosome 6q25, corpus callosum, intellectual disability, next-generation mate-pair sequencing, speech impairment, translocation
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:mau:diva-5351DOI: 10.1111/j.1399-0004.2011.01755.xISI: 000308645800009PubMedID: 21801163Scopus ID: 2-s2.0-84865071031Local ID: 13086OAI: oai:DiVA.org:mau-5351DiVA, id: diva2:1402206
2020-02-282020-02-282025-09-11Bibliographically approved